Drug Interactions of Metformin Involving Drug Transporter Proteins

Pakkir Maideen, Naina Mohamed and Jumale, Abdurazak and Balasubramaniam, Rajkapoor (2017) Drug Interactions of Metformin Involving Drug Transporter Proteins. Advanced Pharmaceutical Bulletin, 7 (4). pp. 501-505. ISSN 2228-5881

[thumbnail of apb-7-501.pdf] Text
apb-7-501.pdf - Published Version

Download (436kB)

Abstract

Metformin is a most widely used medication all around the world to treat Type 2 diabetes mellitus. It is also found to be effective against various conditions including, Prediabetes, Gestational diabetes mellitus (GDM), Polycystic Ovarian Syndrome (PCOS), Obesity, Cancer, etc. It is a cationic drug and it depends Organic Cation Transporters (OCTs) and Multidrug and Toxin Extruders (MATEs) mostly for its pharmacokinetics movement. The probability of drug interaction increases with the number of concomitant medications. This article focuses the drug interactions of metformin and most of them are linked to the inhibition of OCTs and MATEs leading to increased plasma metformin concentrations and subsequent elevation of risk of Metformin Associated Lactic Acidosis (MALA). By identifying the drugs inhibiting OCTs and MATEs, the healthcare professionals can predict the drug interactions of metformin.

Item Type: Article
Subjects: Library Keep > Medical Science
Depositing User: Unnamed user with email support@librarykeep.com
Date Deposited: 18 Apr 2023 07:56
Last Modified: 06 Feb 2024 04:29
URI: http://archive.jibiology.com/id/eprint/599

Actions (login required)

View Item
View Item